Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.839
-0.023 (-2.68%)
Nov 21, 2024, 3:12 PM EST - Market open
Carisma Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 35 | 118 | - | - | - |
| Enterprise Value | 11 | 27 | - | - | - |
| Last Close Price | 0.86 | 2.93 | - | - | - |
| PS Ratio | 1.75 | 7.93 | - | - | - |
| PB Ratio | -3.67 | 4.46 | - | - | - |
| P/TBV Ratio | - | 4.46 | - | - | - |
| EV/Sales Ratio | 0.55 | 1.80 | - | - | - |
| Debt / Equity Ratio | -0.30 | 0.12 | -1.15 | 0.10 | 0.07 |
| Asset Turnover | 0.27 | 0.18 | 0.18 | - | - |
| Quick Ratio | 2.66 | 4.88 | 2.64 | 3.71 | 9.12 |
| Current Ratio | 3.23 | 5.06 | 2.78 | 3.87 | 9.34 |
| Return on Equity (ROE) | -362.79% | - | - | -107.08% | - |
| Return on Assets (ROA) | -56.08% | -68.59% | -65.24% | -54.30% | - |
| Return on Capital (ROIC) | -202.41% | -317.29% | -206.73% | -61.99% | - |
| Earnings Yield | -177.20% | -73.47% | - | - | - |
| FCF Yield | -189.82% | -69.61% | - | - | - |
| Buyback Yield / Dilution | -71.70% | -1475.33% | -96.30% | -1.95% | - |
| Total Shareholder Return | -71.70% | -1475.33% | -96.30% | -1.95% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.